SAB Biotherapeutics, Inc.

Biotechnology • Healthcare • Miami Beach, FL, United States • SABSW (NCM)

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.

605 679 6980 777 W 41st St., Miami Beach, FL 33140, United States

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

SAB Biotherapeutics, Inc. (NASDAQ:SABS) Sees Significant Increase in Short Interest - MarketBeat

MarketBeat • Dec 31

SAB Biotherapeutics Launches New $75 Million ATM Program - The Globe and Mail

The Globe and Mail • Dec 30

SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners are individual investors who got richer after stock soared 22% last week - Yahoo Finance

Yahoo Finance • Nov 22

Guggenheim initiates SAB Biotherapeutics stock with Buy rating on T1D potential - Investing.com

Investing.com • Dec 19

Guggenheim Initiates Coverage of SAB Biotherapeutics (SABS) with Buy Recommendation - Nasdaq

Nasdaq • Dec 20

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has SAB Biotherapeutics, Inc. had layoffs?

No layoff events have been recorded for SAB Biotherapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does SAB Biotherapeutics, Inc. have?

SAB Biotherapeutics, Inc. has approximately 63 employees.

What industry is SAB Biotherapeutics, Inc. in?

SAB Biotherapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is SAB Biotherapeutics, Inc. a publicly traded company?

Yes, SAB Biotherapeutics, Inc. is publicly traded under the ticker symbol SABSW on the NCM.

Where is SAB Biotherapeutics, Inc. headquartered?

SAB Biotherapeutics, Inc. is headquartered in Miami Beach, FL, United States at 777 W 41st St., Miami Beach, FL 33140, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.